Jommi C, Ravasio R. The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA). AboutOpen [Internet]. 2019 Nov. 21 [cited 2024 Jul. 3];6(1):78-85. Available from: https://journals.aboutscience.eu/index.php/aboutopen/article/view/302